IDXX · NASDAQ · Health Care Equipment
Stock since the trade -3.3% · S&P 500 -0.8% · to Oct 1Traded 31 days after resultsStock within 2% of its 52-week low
12K → 9,568 shares held−19% of their stake
A board member of Idexx Laboratories sold $1.17M of Idexx Laboratories shares. Nobody planned it ahead of time.
Director plans to sell ~$1.17M of Idexx Laboratories
Planned, from payStock since the trade -18.5% · S&P 500 +12.3% · to Oct 1Traded 29 days after resultsStock down 11% in the previous month
20K → 18K shares held−9% of their stake
Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
95K → 91K shares held−4% of their stake
The boss of Idexx Laboratories sold $2.41M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
98K → 95K shares held−3% of their stake
The boss of Idexx Laboratories sold $1.88M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
91K → 88K shares held−3% of their stake
The boss of Idexx Laboratories sold $1.89M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
86K → 84K shares held−3% of their stake
The boss of Idexx Laboratories sold $1.72M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
105K → 103K shares held−2% of their stake
The boss of Idexx Laboratories sold $1.09M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
101K → 99K shares held−1% of their stake
The boss of Idexx Laboratories sold $976K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
99K → 98K shares held−1% of their stake
The boss of Idexx Laboratories sold $882K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
107K → 106K shares held−1% of their stake
The boss of Idexx Laboratories sold $834K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
88K → 87K shares held−1% of their stake
The boss of Idexx Laboratories sold $793K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
103K → 102K shares held−1% of their stake
The boss of Idexx Laboratories sold $765K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
102K → 101K shares held−1% of their stake
The boss of Idexx Laboratories sold $727K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
106K → 105K shares held−1% of their stake
The boss of Idexx Laboratories sold $713K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
87K → 86K shares held−1% of their stake
The boss of Idexx Laboratories sold $662K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1Traded 24 days after results
23K → 20K shares held−12% of their stake
Idexx Laboratories's Executive Vice President sold $1.78M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
16K → 13K shares held−17% of their stake
Idexx Laboratories's Executive Vice President sold $1.69M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
17K → 16K shares held−7% of their stake
Idexx Laboratories's Executive Vice President sold $807K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
2,112 → 1,167 shares held−45% of their stake
A board member of Idexx Laboratories sold $594K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
1,167 → 648 shares held−44% of their stake
A board member of Idexx Laboratories sold $326K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
13K → 13K shares held−5% of their stake
Idexx Laboratories's Executive Vice President sold $433K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
18K → 18K shares held−3% of their stake
Idexx Laboratories's Executive Vice President sold $284K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
18K → 17K shares held−1% of their stake
Idexx Laboratories's Executive Vice President sold $128K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1Traded 15 days after results
13K → 13K shares held
Idexx Laboratories's Executive Vice President sold $25K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
13K → 9,863 shares held−22% of their stake
Idexx Laboratories's Executive Vice President sold $1.82M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
17K → 15K shares held−16% of their stake
Idexx Laboratories's Executive Vice President sold $1.8M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
20K → 17K shares held−11% of their stake
Idexx Laboratories's Executive Vice President sold $1.39M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
21K → 20K shares held−5% of their stake
Idexx Laboratories's Executive Vice President sold $727K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
15K → 14K shares held−7% of their stake
Idexx Laboratories's Executive Vice President sold $686K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
14K → 13K shares held−7% of their stake
Idexx Laboratories's Executive Vice President sold $627K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
20K → 20K shares held−2% of their stake
Idexx Laboratories's Executive Vice President sold $256K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -19.9% · S&P 500 +10.4% · to Oct 1Traded 8 days after results
9,863 → 9,823 shares held
Idexx Laboratories's Executive Vice President sold $26K of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1Traded 4 days after resultsStock within 2% of its 52-week high, after a 12% rise in the previous month
31K → 25K shares held−17% of their stake
Idexx Laboratories's Executive Vice President sold $3.59M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1Traded 4 days after resultsStock within 2% of its 52-week high, after a 12% rise in the previous month
25K → 24K shares held−6% of their stake
Idexx Laboratories's Executive Vice President sold $1.03M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1Traded 4 days after resultsStock within 2% of its 52-week high, after a 12% rise in the previous month
24K → 23K shares held−6% of their stake
Idexx Laboratories's Executive Vice President sold $1.03M of Idexx Laboratories shares. Nobody planned it ahead of time.
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1Traded 4 days after resultsStock within 2% of its 52-week high, after a 12% rise in the previous month
23K → 21K shares held−6% of their stake
Idexx Laboratories's Executive Vice President sold $972K of Idexx Laboratories shares. Nobody planned it ahead of time.
